Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
Price, D., Burkill, S., Eileen, W., Wechsler, M. E., Denton, E., Tran, T. N., Martin, N., Katial, R., Barker, P., Maspero, J. F., Hew, M., Brusselle, G., Christoff, G., Sadatsafavi, M., Torres-Duque, C. A., Porsbjerg, C. M., Ulrik, C., Hansen, S., Altraja, A., Bourdin, A., Papadopoulos, N. G., Kostikas, K., Salvi, S., Costello, R. W., Puggioni, F., Iwanaga, T., Rhee, C. K., Al-Ahmad, M., Larenas-Linnemann, D., Fonseca, J. A., Cosio, B. G., Siyue, M. K., Kirenga, B., Sheu, C., Tsai, M., Mahboub, B., Busby, J., Heaney, L. G., Pfeffer, P. E., Patel, P. H., Hoyte, F. L., Liu, Y., Lyu, J., Goh, C., Uthaman, T., Henley, W., ISAR EMBER
European Respiratory Society (ERS) International Congress., 2814
Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)
Loewenthal, L., Busby, J., McDowell, R. D., Brown, T., Burhan, H., Chaudhuri, R., Dennison, P., Dodd, J. W., Doe, S., Faruqi, S., Gore, R., Idris, E., Jackson, D. J., Patel, M., Pantin, T., Pavord, I. D., Pfeffer, P. E., Price, D., Siddiqui, S., Heaney, L. G., Menzies-Gow, A.
European Respiratory Society (ERS) International Congress., 308
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
European Respiratory Society (ERS) International Congress., pp. 1552
Patient-reported barriers to accepting a technological adherence package in the MAGNIFY trial
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Davis, S., Price, D.
European Respiratory Society (ERS) International Congress., 3402
Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Burkill, S., Porsbjerg, C. M., Bourdin, A., Tran, T. N., Martin, N., Katial, R., Barker, P., Wechsler, M. E., Maspero, J. F., Bosnic-Anticevich, S., Chung, L. P., Katsoulotos, G., Christoff, G., Popov, T. A., Sadatsafavi, M., Torres-Duque, C. A., Ulrik, C., Assing, K. D., Hansen, S., Altraja, A., Lehtimäki, L. A., Papadopoulos, N. G., Kostikas, K., Salvi, S., Costello, R. W., Puggioni, F., Iwanaga, T., Rhee, C. K., Al-Ahmad, M., Larenas-Linnemann, D., Fonseca, J. A., Amaral, R., Al-Lehebi, R., Perez de Llano, L., Kirenga, B., Tsai, M., Mahboub, B., Pfeffer, P. E., Henley, W., Liu, Y., Lyu, J., Goh, C., Uthaman, T., Price, D., ISAR IGNITE
European Respiratory Society (ERS) International Congress., 3305